About this book
"Antimicrobial Resistance in Developing Countries, edited by Drs. Anibal Sosa and Denis Byarugaba, and their associate editors is unique in focusing on antimicrobial resistance as it relates to, and threatens developing countries. It is curious that it has taken this long to produce a book dedicated to antibiotic resistance in this part of the world. One can ask "why?", since resistance is and has been so common there. In fact, whereas resistance has been addressed for the past four decades by experts in the industrialized world, studies describing the problem and the public health situation in the developing world have lagged behind. Although we have learned much from studies of the genetics and molecular biology of the problem from investigations in industrialized countries, it is in developing countries where more studies and efforts are needed. With travel encouraging the transport of microbes, the information in this book will have wide sweeping benefit, not only for developing countries, but also for the world at large. Surveillance of resistance and the prevention of resistance need attention on a worldwide basis. Improving antibiotic use requires a global effort".
Prof. Stuart B. Levy
Tufts University School of Medicine
The Alliance for Prudent Use of Antibiotics Boston, MA
Researchers, scientists, professionals, clinicians, physicians, graduate students in the fields of microbiology, infectious disease, public health, immunology, and pharmaceutical sciences
Table of contents
Section I: General Issues in Antimicrobial Resistance. Global perspectives of the Resistance Problem.- Mechanisms of Resistance.- Poverty and Root Causes of Resistance in Developing Countries.- What the Future Holds for Resistance in Developing Countries.- The Introduction of Antimicrobial Agents in Poor-resource Countries: Impact on the Emergence of Resistance.-
Section II: The Human Impact of Resistance. HIV Resistance in Developing Countries.- Drug Resistance in Malaria in Developing Countries.- Drug Resistance in Tuberculosis in Developing Countries.- Antifungal Drug Resistance in Developing Countries.- Antimicrobial Resistance in African Trypanosomiasis.- Resistance in Enteric Pathogens in Developing Countries.-Bacterial Resistant Infections in Resource-Limited Countries.- Prevalence of Resistant Enterococci in Developing Countries.- Antimicrobial Resistance in Gram-negative Bacteria from Developing Countries.- Resistance in Reservoirs and Human Commensals.-
Section III: Antimicrobial Use and Misuse. Determinants of Antimicrobial Use: Poorly Understood - Poorly Researched.- Antimicrobial Use and Antimicrobial Resistance in African Countries.- Antimicrobial Use and Antimicrobial Resistance in Asian Countries.- Antimicrobial Use and Antimicrobial Resistance in Latin America and the Caribbean Countries.- Hospital Infections by Antimicrobial Resistant Organisms in Developing Countries.-
Section IV: Cost, Policy and Regulation of Antimicrobials. Economic Burden of Antimicrobial Resistance.- Health Systems Strengthening to Improve Access to Antimicrobials and the Containment of Resistance.- The Role of Unregulated Sale and Dispensing of Antimicrobial Agents on the Development of Antimicrobial Resistance in Developing Countries.- Counterfeit and Substandard Anti-Infectives in Developing Countries.-
Section V: Strategies to contain AMR. Containment of Antimicrobial Resistance in Developing Countries & Lessons Learned.- Surveillance of Antimicrobial Resistance.- Vaccines: A Cost-effective Strategy to Contain Antimicrobial Resistance.- Teaching Antibiotic Prescription Practices in Medical Schools in Developing Countries.- Containing Global Antibiotic Resistance: Ethical Drug Promotion in the Developing World.- News Media Reporting of Antimicrobial Resistance in Latin America and India.